date:Nov 21, 2018
Active medical device surveillance will better protect patients by continuously generating, accessing, and evaluating large data sets on device performance and clinical outcomes associated with device use in routine clinical practice. It also improves the FDAs ability to link adverse events with specific devices, so we can act quickly with manufacturers and healthcare providers to make timelier, evidence-based decisions to mitigate device problems and keep patients safe.
Implementing a nationa